Abstract

BackgroundZoledronic acid is a bisphosphonate indicated for the prevention of skeletal-related events in patients with advanced malignancies involving bone and treatment of hypercalcaemia of malignancy. According to data sheet Zometa...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call